Sign Out
Special precautions for disposal and other handling: Instructions for dilution: The product should be prepared by a healthcare professional using aseptic technique. Do not shake the vial. A sterile needle and syringe should be used to prepare the diluted infusion solution.
The product is intended for single use only.
Do not use the concentrate if discoloured or if the concentrate contains foreign particulate matter (see Description).
Medicinal product must be diluted before administration. Solutions for intravenous administration are prepared by dilution of the concentrate into an infusion bag containing isotonic sodium chloride 9 mg/mL (0.9%) solution for injection (300 mg/250 mL or 600 mg/500 mL), to a final ocrelizumab concentration of approximately 1.2 mg/mL.
The diluted infusion solution must be administered using an infusion set with a 0.2 or 0.22 micron in-line filter.
Prior to the start of the intravenous infusion, the content of the infusion bag should be at room temperature.
Disposal: Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Incompatibilities: No incompatibilities between this medicinal product and polyvinyl chloride (PVC) or polyolefin (PO) bags and intravenous administration sets have been observed.
This medicinal product must not be mixed with other medicinal products except those previously mentioned in Special precautions for disposal and other handling.
